NCT02902575已完成不适用
The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Fujian Medical University0 个研究点目标入组 80 人开始时间: 2016年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
- 主要终点
- Morbidity
研究概览
简要总结
The purpose of this study is to explore the safety, feasibility, long-term and oncologicaloutcomes of laparoscopic-assisted gastrectomy for advanced Gastric Cancer after neoadjuvant chemotherapy.
详细描述
A prospective single-arm study designed to further evaluate laparoscopic-assisted gastrectomy for advanced Gastric Cancer after neoadjuvant chemotherapy will be performed, to evaluate the safety, feasibility, long-term and oncological outcomes. The evaluation parameters are perioperative mobility and mortality, perioperative clinical efficacy, postoperative life quality, immune function and 3-year survival and recurrence rates.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age from 18 to 75 years
- •Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically by endoscopic biopsy
- •cT2-4aN+M0 at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual Seventh Edition
- •No distant metastasis is observed. And the spleen, pancreas or other adjacent organs are not involved by the tumor.
- •Performance status of 0 or 1 on Eastern Cooperative Oncology Group scale (ECOG)
- •American Society of Anesthesiology score (ASA) class I, II, or III
- •Written informed consent
排除标准
- •Women during pregnancy or breast-feeding
- •Severe mental disorder
- •History of previous upper abdominal surgery (except laparoscopic cholecystectomy, previous gastrectomy, endoscopic mucosal resection or endoscopic submucosal dissection)
- •History of previous gastrectomy, endoscopic mucosal resection or endoscopic submucosal dissection
- •History of other malignant disease within past five years
- •History of unstable angina or myocardial infarction within past six months
- •History of cerebrovascular accident within past six months
- •History of continuous systematic administration of corticosteroids within one month
- •Requirement of simultaneous surgery for other disease
- •Emergency surgery due to complication (bleeding, obstruction or perforation) caused by gastric cancer
- •FEV1<50% of predicted values
结局指标
主要结局
Morbidity
时间窗: 30 days
The early postoperative complication are defined as the event observed within 30 days after surgery.Postoperative complications were graded according to the Clavien-Dindo classification system
次要结局
- 3-year overall survival rate(36 months)
- Duration of hospital stay(10 days)
- The values of C-reactive protein(7 days)
- Pathological response(30 days)
- The number of lymph node dissection(1 day)
- Time to first flatus(10 days)
- Blood transfusion(10 days)
- 3-year disease free survival rate(36 months)
- Time to first liquid diet(10 days)
- Time of operation(1 day)
- Intraoperative injury(1 days)
- Mortality(30 days)
- Time to first ambulation(10 days)
- Rates of combined organ resection(1 day)
- Time to soft diet(10 days)
- The number of positive lymph nodes(1 days)
- The amount of use of titanium clip(1 days)
- The values of white blood cell count(7 days)
- Radiological response(30 days)
- Scale the amount of abdominal drainage(10 days)
- The results of endoscopy(12 month)
- The values of hemoglobin(7 days)
- Adverse events(30 days)
- The daily highest body temperature(7 days)
- 3-year recurrence pattern(36 months)
- The variation of weight(12 months)
- Intraoperative lymph node dissection time(1 days)
- Intraoperative blood loss(1 days)
- The rate of conversion to laparotomy(1 days)
- The variation of albumin(12 month)
- The values of prealbumin(7 days)
- Late postoperative complication(36 months)
研究者
Chang-Ming Huang, Prof.
Professor
Fujian Medical University
相似试验
Enrolling By Invitation
不适用
The Safety, Feasibility and Oncological Outcomes of Laparoscopic Completion Total Gastrectomy for Remnant Gastric CancerRemnant Gastric CancerNCT02792881Fujian Medical University50
Unknown
不适用
Laparoscopy-Assisted Surgery for Carcinoma of the Low RectumRectal CarcinomaNCT01899547Fujian Medical University1,070
Unknown
2 期
Phase II Trial to Evaluate Laparoscopic Surgery for Stage 0/I Rectal CarcinomaRectal CancerNCT00635466Japan Society of Laparoscopic Colorectal Surgery495
已完成
不适用
Study of the safety and efficacy in laparoscopic sleeve gastrectomy for obesityObesityJPRN-UMIN000020717Okayama University10
已完成
不适用
Feasibility, safety and efficacy of laparoscopic sleeve gastrectomy for obese patients with BMI over 32.0 kg/m2: A prospective, non-randomized, single center studyObesityJPRN-UMIN000024732Hamamatsu University School of Medicine5